Dr. Isaacs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2279 45th St
Sacramento, CA 95817Phone+1 916-734-5959Fax+1 972-474-4127
Summary
- PGY-3 internal medicine resident physician at UCLA. Expertise in health policy, public health, advocacy, and street medicine. Committed to partnering with underserved and marginalized populations. Interested in clinical research to enhance oncologic treatment access and combat social determinants of health. Applying for a fellowship in hematology/oncology.
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2021 - 2024
- University of California, Davis, School of MedicineClass of 2021
- UC Davis School of MedicineMPH, Epidemiology , “Excellence in Public Health” Award, 2016 - 2017
Certifications & Licensure
- CA State Medical License 2023 - 2025
Publications & Presentations
PubMed
- 7 citationsManagement and Outcomes of Adults Diagnosed with Acute Pulmonary Embolism in Primary Care: Community-Based Retrospective Cohort Study.David R Vinson, Erik R Hofmann, Elizabeth J Johnson, Suresh Rangarajan, Jie Huang
Journal of General Internal Medicine. 2022-11-01 - 7 citations"Outpatient Management" of Pulmonary Embolism Defined in the Primary Literature: A Narrative Review.Judy Shan, Dayna J Isaacs, Harjot Bath, Elizabeth J Johnson, Dani Julien
The Permanente Journal. 2021-07-28 - 1 citationsSafety and efficacy of immune checkpoint inhibitor cancer therapy in patients with preexisting type 1 diabetes mellitus.Robin Hilder, Karen Tsai, Zoe Quandt, Dayna Isaacs, Alexandra Drakaki
Frontiers in Endocrinology. 2023-01-01
Journal Articles
- Risk of severe immune-related adverse events in cancer patients with pre-existing autoimmunity receiving immune checkpoint inhibitor therapyDayna Jill Isaacs, Nikhita Kathuria-Prakash, Robin Hilder, Melissa G. Lechner, Alexandra Drakaki, Current Cancer Reports, 1/29/2024
- Safety and efficacy of immune checkpoint inhibitor cancer therapy in patients with pre-existing type 1 diabetes mellitus• Hilder R, Tsai K, Quandt Z, Isaacs DJ, Drakaki D, Xing Y, In GK, Angell TE, Lechner MG, Frontiers in Endocrinology, 10/11/2023
Authored Content
- We Should Disaffiliate from the AOA Honor Medical SocietyFebruary 2024
Press Mentions
- What Residents Are Getting Paid in 2024October 24th, 2024
- Residency Unions Are Winning Improved ContractsAugust 26th, 2024
- What I wish I knew in residency about collective bargainingMarch 21st, 2024
- Join now to see all
Professional Memberships
- Member
- Member
- Vice Chair of the Resident & Fellow Section
- California Medical AssociationVice Chair of Policy Development for the Resident & Fellow Section
- Committee of Interns and ResidentsUC Southern California Regional Vice President
- Member
External Links
- LinkedInhttps://www.linkedin.com/in/daynaisaacs/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: